Journal Title：Therapeutic Advances In Ophthalmology

The Journal of Advances in Ophthalmic Treatment is an academic journal dedicated to the latest research progress in the field of ophthalmic medicine. It covers all aspects of ophthalmic treatment, including but not limited to retinal diseases, corneal transplantation, diabetes retinopathy, gene therapy and ophthalmic surgical techniques. According to search results, significant progress has been made in the field of ophthalmology in 2021, including the emergence of innovative drugs, advances in cutting-edge gene therapy applications, and breakthroughs in the treatment of major ophthalmic diseases.

The development of ophthalmic gene therapy has also been a hot topic in recent years. Many hereditary ophthalmic diseases occur due to genetic defects, and gene therapy provides new hope for treating these diseases. In the next 1-10 years, significant progress is expected in the field of ophthalmic gene therapy, including the expansion of the patient population for indications, the development of non viral vectors that break through gene load limitations, and the application of new technologies such as gene editing therapy.

《眼科治療進展雜志》是一本專注于眼科醫(yī)學領域最新研究進展的學術期刊。它涵蓋了眼科治療的各個方面，包括但不限于視網(wǎng)膜疾病、角膜移植、糖尿病視網(wǎng)膜病變、基因療法以及眼科手術技術等。根據(jù)搜索結果，2021年眼科領域取得了顯著的進展，其中包括創(chuàng)新藥物的問世、前沿的基因治療應用進展以及眼科重大疾病的治療突破。

眼科基因療法的發(fā)展也是近年來的一個熱點，許多遺傳性眼科疾病由于基因缺陷而發(fā)生，而基因療法提供了治療這些疾病的新希望。未來1-10年，眼科基因療法領域有望發(fā)生重大進展，包括適應癥患者群體的擴大、突破基因載荷限制的非病毒載體的開發(fā)，以及新技術如基因編輯療法的應用。

Therapeutic Advances In Ophthalmology由SAGE Publishing出版商出版，收稿方向涵蓋OPHTHALMOLOGY全領域，平均審稿速度 12 Weeks ，影響因子指數(shù)2.3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。